Insider Trading: Celgene Corp (CELG.O)

CELG.O on Nasdaq

117.99USD
1:44pm EST
Change (% chg)

$-2.33 (-1.93%)
Prev Close
$120.31
Open
$120.00
Day's High
$120.19
Day's Low
$116.34
Volume
4,530,919
Avg. Vol
5,611,138
52-wk High
$125.45
52-wk Low
$66.85

Search Stocks
LOUGHLIN JAMES J
Trading Date Type Shares Traded Price Shares Held
21 Aug 2014 Buy 20,000 $28.65 18,818
21 Aug 2014 Sell 20,000 $91.25 18,818
12 Jun 2014 Buy 1,033 $0.00 9,409
11 Jun 2014 Buy 1,033 $0.00 9,409
15 Jun 2013 Buy 685 $0.00 7,343
12 Jun 2013 Buy 1,033 $0.00 7,343

Institutional Holders

% Shares Owned: 83.40%
# of Holders: 1,471
Total Shares Held: 667,722,643
3 Mo. Net Change: 5,317,938
# New Positions: 178
# Closed Positions: 39
# Increased Positions: 619
# Reduced Positions: 564
# Net Buyers: 55

Officers & Directors

Name Age Since Current Position

Robert Hugin

59 2011 Chairman of the Board, President, Chief Executive Officer

Mark Alles

55 2014 President, Chief Operating Officer

Peter Kellogg

58 2014 Chief Financial Officer, Executive Vice President

Jacqualyn Fouse

52 2014 President - Hematology & Oncology

Tuomo Patsi

President - Europe, Middle East and Africa (EMEA)

Scott Smith

2014 President - Inflammation & Immunology

Perry Karsen

58 2012 Chief Operations Officer, Executive Vice President

Lawrence Stein

64 2012 Executive Vice President, General Counsel, Corporate Secretary

Thomas Daniel

60 2012 Executive Vice President, President - Research and Early Development

Michael Casey

68 2007 Lead Independent Director

Richard Barker

65 2012 Independent Director

Carrie Cox

57 2009 Independent Director

Michael Friedman

70 2011 Independent Director

Gilla Kaplan

67 1998 Independent Director

James Loughlin

71 2007 Independent Director

Ernest Mario

76 2007 Independent Director
Search Stocks